GlobalData, the industry analysis specialist, has released its new report, Healthcare, Regulatory and Reimbursement Landscape Venezuela. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape of Venezuela. The report identifies the key trends in the healthcare market of Venezuela.
To read more ....http://www.salisonline.org/study/healthcare-regulatory-and-reimbursement-landscape-venezuela.asp#discription-tab
Healthcare, regulatory and reimbursement landscape venezuela
1. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.com
Healthcare, Regulatory and Reimbursement Landscape - Venezuela
Summary
GlobalData, the industry analysis specialist, has released its new report, Healthcare, Regulatory
and Reimbursement Landscape Venezuela. The report is an essential source of information
and analysis on the healthcare, regulatory and reimbursement landscape of Venezuela. The report
identifies the key trends in the healthcare market of Venezuela. The report also provides
insights into the demographic, regulatory and reimbursement landscapes and the healthcare
infrastructure of Venezuela. Most importantly, the report provides valuable insights into the
trends and segmentation of the pharmaceutical market. This report is built using data and
information sourced from proprietary databases, secondary research and in-house analysis by
GlobalDatas team of industry experts.
Venezuela was the 45th most populated country in the world with a population of approximately
28 million in 2012. The population of Venezuela is increasing due to the high birth rate and low
mortality rate as well as an increase in life expectancy. The increase in the working-age
population supports the country in its development while the increasing elderly population is a
matter of concern for policy planners. The pharmaceutical market in Venezuela was estimated at
$7 billion in 2011 and is expected to reach approximately $35.2 billion by 2020 at a projected
Compound Annual Growth Rate (CAGR) of 19.7% between 2012 and 2020. However, the
Venezuelan currency was depreciated by the government for pharmaceutical products in 2011.
Therefore, GlobalData estimates that the pharmaceutical market will be depreciated and valued
at $4.2 billion in 2011, and will reach $8.5 billion in 2020 at a CAGR of 8.2% from 2006 to
2020.
The positive trend in the healthcare market of Venezuela can be attributed primarily to
The increasing elderly population
Increasing access to healthcare facilities
Government initiatives in the healthcare sector
The increasing affordability of healthcare
2. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.com
Scope
The report provides information on the healthcare, regulatory and reimbursement landscape of
Venezuela. The scope includes
An overview of the pharmaceutical market of Venezuela including the market size,
market segmentation, key drivers and barriers for the market.
Profile and SWOT analysis of the major players in the pharmaceutical market. Key
players covered for the pharmaceutical market are Pfizer, GlaxoSmithKline, Sanofi,
Novartis and Groupo Farma.
An insightful review on the reimbursement and regulatory landscape. Analysis includes
details of the healthcare reimbursement process, regulatory agencies and the marketing
authorization process for new drugs and medical devices for Venezuela.
A detailed analysis of the political and economic environment of Venezuela, including
the economic indicators, demographics, healthcare infrastructure and healthcare
expenditure.
An overview of the opportunities and challenges for growth that exist in the healthcare
market of Venezuela.
Reasons to buy
This report comprehensively covers the pharmaceutical market of Venezuela. The report
will enhance your decision making capability. It will allow you to
Develop business strategies by understanding the trends shaping and driving the
healthcare market of Venezuela.
Drive revenues by understanding the key trends, reimbursement and regulatory policies,
pharmaceutical market segments and companies likely to impact the Venezuelan
healthcare market in future.
Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
Organize your sales and marketing efforts by identifying the market categories and
segments that present the biggest opportunities for consolidations, investments and
strategic partnerships.
Identify, understand and capitalize on the opportunities and challenges in the healthcare
market of Venezuela.
BUY NOW
3. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.com
Table of Contents
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 Report Guidance 10
3 Overview of the Pharmaceutical and Medical Devices Market 11
3.1 Pharmaceutical Market 11
3.1.1 Market Overview 11
3.1.2 Supply Channels 14
3.1.3 Market Segments 16
3.1.4 Major Disease Areas 19
3.1.5 Major Players 20
3.2 Medical Device Market 46
3.2.1 Market Overview 46
3.3 Market Drivers and Barriers 46
3.3.1 Drivers 46
3.3.2 Barriers 47
4 Market Access 49
4.1 Reimbursement and Payer Landscape 49
4.1.1 Reimbursement Process 52
4.1.2 Overview of Insurance Providers 53
4.1.3 Patient Share in Healthcare Spending 54
4.1.4 Price Trend for Medicines 55
4.2 Regulatory Landscape 56
4.2.1 Overview of Regulatory Agencies 56
4.2.2 Registration Procedure for New Drug 56
4.2.3 Medical Device Approval Process 58
4.2.4 Licensing Process for Pharmaceutical Manufacturing 58
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 59
4.2.6 Intellectual Property Rights 59
4.2.7 Clinical Trial Regulations 64
4.2.8 Pharmaceutical Advertising Regulations 66
4.2.9 Pharmacy Regulations 67
4.2.10 Labeling and Packaging Regulations 68
4. http://www.salisonline.org Tel: +1-518-618-1030 sales@researchmoz.com
5 Country Analysis 70
5.1 Political Environment 70
5.1.1 Political Structure 70
5.1.2 Analysis of the Current Political Environment 71
5.1.3 Healthcare Policy Initiatives 72
5.2 Economic Landscape 72
5.3 Economic Indicators 74
5.3.1 Gross Domestic Product 74
5.3.2 Gross National Income 78
5.3.3 Inflation 79
5.3.4 Currency Exchange Rate 83
5.3.5 Foreign Direct Investment 85
5.3.6 Foreign Exchange Reserves 86
5.3.7 Trade Balance 87
5.3.8 Government Structural Balance 89
5.3.9 Government Gross Debt 91
5.3.10 Major Industries 93
5.4 Demography 94
5.4.1 Population 94
5.4.2 Education and Literacy 113
5.4.3 Employment 115
5.4.4 Disease Burden 117
5.5 Healthcare Infrastructure 118
5.5.1 Healthcare Facilities 118
5.5.2 Healthcare Parameters 124
5.5.3 Environmental Health 126
5.6 Healthcare Expenditure 130
5.6.1 Overview 130
5.6.2 Share of Public and Private Sectors 131
5.6.3 Spending in Healthcare R&D 131
5.7 Trade Associations 132
5.7.1 Venezuelan Chamber of Medicine 132
5.7.2 Chamber of Pharmaceutical Industry 132
5.7.3 Chamber of Non-prescription Medicines 132
5.7.4 Venezuelan Association of Distributors of Medical Equipment, Dental Laboratories and
Allied 132
5.7.5 Venezuelan Chamber of Pharmacy 132
6 Opportunities and Challenges 133
6.1 Opportunities 133
6.2 Challenges 134